Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 10/2003

01.10.2003 | Original Article

Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells

verfasst von: Laura Sanz, Mónica Feijóo, Belén Blanco, Antonio Serrano, Luis Álvarez-Vallina

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 10/2003

Einloggen, um Zugang zu erhalten

Abstract

Tumor-induced blood vessel formation is a key process for the growth and spread of solid tumors, traditionally attributed to activated host endothelial cells (angiogenesis). Recently, highly aggressive cancer cells have been shown to form vascular channels in the absence of endothelial cells (vasculogenic mimicry). In this work, we have focused on the common dependence of both processes in their interactions with the surrounding extracellular matrix. We had previously described a human recombinant anti-laminin antibody that blocked the capillary morphogenesis of human endothelial cells. Here, we demonstrate that the purified antibody is capable of inhibiting channel formation by human cancer cells, suggesting a common morphogenic pathway in both processes. Moreover, matrix-embedded cells producing antibody fragments may render the surrounding matrix non-permissive for aggressive tumor cells. These results open the way for the development of new therapeutic strategies for cancer.
Literatur
1.
Zurück zum Zitat Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683PubMed Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683PubMed
2.
Zurück zum Zitat Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1:219CrossRef Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1:219CrossRef
3.
Zurück zum Zitat Álvarez-Vallina L (2001) Genetic approaches for antigen-selective cell therapy. Curr Gene Ther 1:385PubMed Álvarez-Vallina L (2001) Genetic approaches for antigen-selective cell therapy. Curr Gene Ther 1:385PubMed
4.
Zurück zum Zitat Bischoff J (1997) Cell adhesion and angiogenesis. J Clin Invest 100:S37PubMed Bischoff J (1997) Cell adhesion and angiogenesis. J Clin Invest 100:S37PubMed
6.
Zurück zum Zitat Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536PubMed Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536PubMed
7.
Zurück zum Zitat Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249PubMed Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249PubMed
8.
Zurück zum Zitat Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608CrossRefPubMed Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608CrossRefPubMed
9.
Zurück zum Zitat Chester J, Ruchatz A, Gough M, Crittenden M, Chong H, Loic-Cosset F, Diaz RM, Harrington K, Álvarez-Vallina L, Vile R (2002) Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Nat Biotechnol 20:256CrossRefPubMed Chester J, Ruchatz A, Gough M, Crittenden M, Chong H, Loic-Cosset F, Diaz RM, Harrington K, Álvarez-Vallina L, Vile R (2002) Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Nat Biotechnol 20:256CrossRefPubMed
10.
Zurück zum Zitat Colognato H, Yurchenco P (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218:213PubMed Colognato H, Yurchenco P (2000) Form and function: the laminin family of heterotrimers. Dev Dyn 218:213PubMed
11.
Zurück zum Zitat Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361PubMed Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361PubMed
12.
Zurück zum Zitat Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175:40930. Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175:40930.
13.
Zurück zum Zitat Hawkins RE, Russell SJ, Winter G (1992) Selection of phage antibodies by binding affinity: mimicking affinity maturation. J Mol Biol 226:889PubMed Hawkins RE, Russell SJ, Winter G (1992) Selection of phage antibodies by binding affinity: mimicking affinity maturation. J Mol Biol 226:889PubMed
14.
Zurück zum Zitat Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 98:8018CrossRefPubMed Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 98:8018CrossRefPubMed
15.
Zurück zum Zitat Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD, Schatteman GC (2002) Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 62:665PubMed Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD, Schatteman GC (2002) Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 62:665PubMed
16.
Zurück zum Zitat Hoang MP, Selim MA, Bentley RC, Burchette JL, Shea CR (2001) CD34 expression in desmoplastic melanoma. J Cutan Pathol 28:508CrossRefPubMed Hoang MP, Selim MA, Bentley RC, Burchette JL, Shea CR (2001) CD34 expression in desmoplastic melanoma. J Cutan Pathol 28:508CrossRefPubMed
17.
Zurück zum Zitat Kobayashi H, Shirakawa K, Kawamoto S, Saga T, Sato N, Hiraga A, Watanabe I, Heike Y, Togashi K, Konishi J, Brechbiel MW, Wakasugi H (2002) Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res 62:860PubMed Kobayashi H, Shirakawa K, Kawamoto S, Saga T, Sato N, Hiraga A, Watanabe I, Heike Y, Togashi K, Konishi J, Brechbiel MW, Wakasugi H (2002) Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res 62:860PubMed
18.
Zurück zum Zitat Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739PubMed Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739PubMed
19.
Zurück zum Zitat McDonald DM, Foss AJ (2000) Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19:109PubMed McDonald DM, Foss AJ (2000) Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19:109PubMed
20.
Zurück zum Zitat McDonald DM, Munn L, Jain RK (2000) Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156:383 McDonald DM, Munn L, Jain RK (2000) Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156:383
21.
Zurück zum Zitat Meyer GT, Matthias LJ, Noack L, Vadas MA, Gamble JR (1997) Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodelling by different populations of endothelial cells. Anat Rec 249:327CrossRefPubMed Meyer GT, Matthias LJ, Noack L, Vadas MA, Gamble JR (1997) Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodelling by different populations of endothelial cells. Anat Rec 249:327CrossRefPubMed
22.
Zurück zum Zitat Rusolahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2:8321 Rusolahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2:8321
23.
Zurück zum Zitat Sanz L, Kristensen P, Russell SJ, Ramírez García JR, Álvarez-Vallina L (2001) Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy. Cancer Immunol Immunother 50:557CrossRefPubMed Sanz L, Kristensen P, Russell SJ, Ramírez García JR, Álvarez-Vallina L (2001) Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy. Cancer Immunol Immunother 50:557CrossRefPubMed
24.
Zurück zum Zitat Sanz L, Kristensen P, Blanco B, Facteau S, Russell SJ, Winter G, Álvarez-Vallina L (2002) Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices. Gene Ther 9:1049CrossRefPubMed Sanz L, Kristensen P, Blanco B, Facteau S, Russell SJ, Winter G, Álvarez-Vallina L (2002) Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices. Gene Ther 9:1049CrossRefPubMed
25.
Zurück zum Zitat Sanz L, Pascual M, Muñoz A, González MA, Hernández Salvador C, Álvarez-Vallina L (2002) Development of a computer-assisted high-throughput screening platform for anti-angiogenic screening. Microvasc Res 63:335CrossRefPubMed Sanz L, Pascual M, Muñoz A, González MA, Hernández Salvador C, Álvarez-Vallina L (2002) Development of a computer-assisted high-throughput screening platform for anti-angiogenic screening. Microvasc Res 63:335CrossRefPubMed
26.
Zurück zum Zitat Satyamoorthy K, DeJesus E, Linnenbach AJ, Kraj B, Kornreich DL, Rendle S, Elder DE, Herlyn M (1997) Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res 7 [Suppl 2]:S35 Satyamoorthy K, DeJesus E, Linnenbach AJ, Kraj B, Kornreich DL, Rendle S, Elder DE, Herlyn M (1997) Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res 7 [Suppl 2]:S35
27.
Zurück zum Zitat Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V, Hendrix MJ (2001) Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322PubMed Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V, Hendrix MJ (2001) Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322PubMed
28.
Zurück zum Zitat Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM, Hendrix MJ (2002) Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50:189CrossRefPubMed Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM, Hendrix MJ (2002) Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50:189CrossRefPubMed
29.
Zurück zum Zitat Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279PubMed Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ (2001) Molecular determinants of ovarian cancer plasticity. Am J Pathol 158:1279PubMed
30.
Zurück zum Zitat Timpl R (1996) Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618PubMed Timpl R (1996) Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618PubMed
31.
Zurück zum Zitat Watson SA, Durrant LG, Morris DL (1990) The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45G. Int J Cancer 45:90PubMed Watson SA, Durrant LG, Morris DL (1990) The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45G. Int J Cancer 45:90PubMed
Metadaten
Titel
Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells
verfasst von
Laura Sanz
Mónica Feijóo
Belén Blanco
Antonio Serrano
Luis Álvarez-Vallina
Publikationsdatum
01.10.2003
Verlag
Springer-Verlag
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 10/2003
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-003-0400-0

Weitere Artikel der Ausgabe 10/2003

Cancer Immunology, Immunotherapy 10/2003 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.